50
Participants
Start Date
April 1, 2018
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2020
BNZ132-1-40
Injectable PEGylated peptide antagonist that binds to the common gamma chain (γc) signaling receptor for the cytokines interleukin (IL)-2, IL-9, and IL-15
City of Hope National Medical Center, Duarte
University of Virginia Cancer Center, Charlottesville
Moffitt Cancer Center, Tampa
The James Cancer Center, Ohio State University, Columbus
Lead Sponsor
Bioniz Therapeutics
INDUSTRY